These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8313785)

  • 1. N-methylformamide as a potential therapeutic approach in colon cancer.
    Del Bufalo D; Bucci B; D'Agnano I; Zupi G
    Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S133-7. PubMed ID: 8313785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line.
    Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M
    Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
    Laudonio N; Zupi G; Erba E; Leonetti C; D'Incalci M
    Br J Cancer; 1990 Mar; 61(3):377-81. PubMed ID: 2328201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of cell cycle perturbations on the effectiveness of N-methylformamide and anti-neoplastic drugs in combination.
    Cucco C; D'Agnano I; Marangolo M; Candiloro A; Zupi G
    Cell Prolif; 1991 May; 24(3):293-303. PubMed ID: 2039805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
    Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
    Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
    Iwakawa M; Tofilon PJ; Arundel C; Milas L
    Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.
    Del Bufalo D; Leonetti C; Bucci B; Amedeo C; Falcioni R; Biroccio A; Zupi G
    Br J Cancer; 1998; 77(2):210-5. PubMed ID: 9460990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of N-methylformamide on the intracellular transport of doxorubicin.
    Calcabrini A; Villa AM; Molinari A; Doglia SM; Arancia G
    Eur J Cell Biol; 1997 Jan; 72(1):61-9. PubMed ID: 9013727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin.
    Scotlandi K; Serra M; Manara MC; Lollini PL; Maurici D; Del Bufalo D; Baldini N
    Int J Cancer; 1994 Jul; 58(1):95-101. PubMed ID: 7912235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the responses of human colon adenocarcinoma cells to X-irradiation and cis-platinum by N-methylformamide (NMF).
    Leith JT; Lee ES; Vayer AJ; Dexter DL; Glicksman AS
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1971-6. PubMed ID: 4055454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X ray responses of a human colon tumor cell line after exposure to the differentiation-inducing agent N-methylformamide: concentration dependence and reversibility characteristics.
    Leith JT; Bliven SF
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1231-7. PubMed ID: 3384724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.
    Cordeiro RF; Savarese TM
    Cancer Res; 1986 Mar; 46(3):1297-305. PubMed ID: 3943098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide.
    Voelcker G
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1183-9. PubMed ID: 26941190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sequential combinations of N-methylformamide with adriamycin on cultured melanoma cells (M14).
    Arancia G; Molinari A; Calcabrini A; Citro G; Villa AM; Verdina A; Zupi G
    Exp Mol Pathol; 1994 Feb; 60(1):12-26. PubMed ID: 8162967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antitumor and antimetastatic activities of adriamycin by a novel N-alkylated dihydropyridine, AC394, and its enantiomers in colon cancer-bearing mice.
    Ohishi K; Morinaga Y; Ohsumi K; Nakagawa R; Suga Y; Tsuji T; Akiyama Y; Tsuruo T
    Cancer Chemother Pharmacol; 1996; 38(5):446-52. PubMed ID: 8765438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-methylformamide on the growth, cell cycle, and glutathione status of murine TLX5 lymphoma cells.
    Bill CA; Gescher A; Hickman JA
    Cancer Res; 1988 Jun; 48(12):3389-93. PubMed ID: 3370637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methylformamide-mediated enhancement of in vitro tumor cell chemosensitivity.
    Tofilon PJ; Vines CM; Milas L
    Cancer Chemother Pharmacol; 1986; 17(3):269-73. PubMed ID: 3742713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
    Planting AS; Klijn JG; Verweij J; Stoter G
    Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal by L-cysteine of the growth inhibitory and glutathione-depleting effects of N-methylformamide and N,N-dimethylformamide.
    Cordeiro RF; Savarese TM
    Biochem Biophys Res Commun; 1984 Jul; 122(2):798-803. PubMed ID: 6466338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.